ZHENGMING SU

857 total citations
37 papers, 683 citations indexed

About

ZHENGMING SU is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, ZHENGMING SU has authored 37 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 24 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in ZHENGMING SU's work include MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (17 papers) and Circular RNAs in diseases (16 papers). ZHENGMING SU is often cited by papers focused on MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (17 papers) and Circular RNAs in diseases (16 papers). ZHENGMING SU collaborates with scholars based in China, United States and Hong Kong. ZHENGMING SU's co-authors include Yongqing Lai, DUQUN CHEN, Shangqi Yang, Yaoting Gui, Zuhu Yu, Liangchao Ni, Yu‐Chi Li, Yifan Li, Xianhan Jiang and Lü Jin and has published in prestigious journals such as Cancer Science, The Prostate and Aging.

In The Last Decade

ZHENGMING SU

37 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
ZHENGMING SU China 19 516 409 108 68 54 37 683
Changbao Qu China 13 475 0.9× 333 0.8× 76 0.7× 30 0.4× 81 1.5× 28 625
Heather Hardin United States 19 595 1.2× 483 1.2× 94 0.9× 70 1.0× 246 4.6× 31 966
Jingping Ge China 18 546 1.1× 417 1.0× 101 0.9× 32 0.5× 71 1.3× 40 719
Zhixin Wang China 11 630 1.2× 626 1.5× 120 1.1× 31 0.5× 45 0.8× 26 781
Fujun Zhao China 14 442 0.9× 243 0.6× 153 1.4× 19 0.3× 97 1.8× 38 683
Feng Qiu China 12 754 1.5× 786 1.9× 88 0.8× 100 1.5× 69 1.3× 17 938
Aditi Rathi United States 7 672 1.3× 145 0.4× 82 0.8× 117 1.7× 125 2.3× 11 810
Tomohiro Kumamoto Japan 14 501 1.0× 437 1.1× 108 1.0× 29 0.4× 70 1.3× 21 635
Zhiming Wang China 15 402 0.8× 320 0.8× 80 0.7× 64 0.9× 154 2.9× 32 638
Takenari Gotanda Japan 13 404 0.8× 212 0.5× 54 0.5× 17 0.3× 142 2.6× 16 581

Countries citing papers authored by ZHENGMING SU

Since Specialization
Citations

This map shows the geographic impact of ZHENGMING SU's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ZHENGMING SU with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ZHENGMING SU more than expected).

Fields of papers citing papers by ZHENGMING SU

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ZHENGMING SU. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ZHENGMING SU. The network helps show where ZHENGMING SU may publish in the future.

Co-authorship network of co-authors of ZHENGMING SU

This figure shows the co-authorship network connecting the top 25 collaborators of ZHENGMING SU. A scholar is included among the top collaborators of ZHENGMING SU based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with ZHENGMING SU. ZHENGMING SU is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
SU, ZHENGMING, et al.. (2021). Bladder Paraganglioma: Three Cases Report and Literature Review. International Medical Case Reports Journal. Volume 14. 765–771. 3 indexed citations
3.
Yi, Ming, Minghua Li, Xia Long, et al.. (2016). miR-520e regulates cell proliferation, apoptosis and migration in breast cancer. Oncology Letters. 12(5). 3543–3548. 14 indexed citations
4.
Li, Yifan, Lü Jin, Jiaju Liu, et al.. (2016). Bellini's duct carcinoma: A report of two cases and a review of the literature. Oncology Letters. 11(6). 3839–3841. 2 indexed citations
5.
Li, Yifan, Yuchi Li, DUQUN CHEN, et al.. (2016). miR-30a-5p in the tumorigenesis of renal cell carcinoma: A tumor suppressive microRNA. Molecular Medicine Reports. 13(5). 4085–4094. 20 indexed citations
6.
Liu, Jiaju, ZHENGMING SU, Yifan Li, et al.. (2016). Xp11.2 translocation renal cell carcinoma with multiple bone metastases: A case report. Oncology Letters. 11(3). 2233–2236. 2 indexed citations
7.
Li, Yifan, DUQUN CHEN, Lü Jin, et al.. (2015). MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis. Molecular Medicine Reports. 13(2). 1895–1901. 26 indexed citations
8.
Zou, Xiaowen, Jianhua Zhong, ZHENGMING SU, et al.. (2015). miR-362-3p targets nemo-like kinase and functions as a tumor suppressor in renal cancer cells. Molecular Medicine Reports. 13(1). 994–1002. 26 indexed citations
9.
Li, Yifan, DUQUN CHEN, Lü Jin, et al.. (2015). Oncogenic microRNA-142-3p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma. Oncology Letters. 11(2). 1235–1241. 32 indexed citations
10.
Li, Yu‐Chi, Lü Jin, Jiaju Liu, et al.. (2015). Identification of miR-130b as an oncogene in renal cell carcinoma. Molecular Medicine Reports. 13(2). 1902–1908. 11 indexed citations
11.
SU, ZHENGMING, DUQUN CHEN, Yifan Li, et al.. (2015). microRNA-184 functions as tumor suppressor in renal cell carcinoma. Experimental and Therapeutic Medicine. 9(3). 961–966. 31 indexed citations
12.
CHEN, DUQUN, Yu‐Chi Li, Zuhu Yu, et al.. (2015). Downregulated microRNA-510-5p acts as a tumor suppressor in renal cell carcinoma. Molecular Medicine Reports. 12(2). 3061–3066. 20 indexed citations
13.
Yu, Zuhu, DUQUN CHEN, ZHENGMING SU, et al.. (2014). miR-886-3p upregulation in clear cell renal cell carcinoma regulates cell migration, proliferation and apoptosis by targeting PITX1. International Journal of Molecular Medicine. 34(5). 1409–1416. 13 indexed citations
14.
CHEN, DUQUN, Yifan Li, ZHENGMING SU, et al.. (2014). Identification of miR-125a-5p as a tumor suppressor of renal cell carcinoma, regulating cellular proliferation, migration and apoptosis. Molecular Medicine Reports. 11(2). 1278–1283. 18 indexed citations
15.
SU, ZHENGMING, Liangchao Ni, Zuhu Yu, et al.. (2014). MicroRNA-451a is associated with cell proliferation, migration and apoptosis in renal cell carcinoma. Molecular Medicine Reports. 11(3). 2248–2254. 32 indexed citations
16.
SU, ZHENGMING, Yadong Wang, Zuhu Yu, et al.. (2014). Bizarre leiomyoma of the scrotum: A case report and review of the literature. Oncology Letters. 7(5). 1701–1703. 4 indexed citations
17.
Yu, Zuhu, Liangchao Ni, DUQUN CHEN, et al.. (2014). Expression and clinical significance of RCDG1 in renal cell carcinoma: A novel renal cancer-associated gene. Molecular Medicine Reports. 10(3). 1583–1589. 7 indexed citations
18.
CHEN, DUQUN, Yifan Li, Zuhu Yu, et al.. (2014). Investigating urachal carcinoma for more than 15 years. Oncology Letters. 8(5). 2279–2283. 24 indexed citations
19.
Yu, Zuhu, Liangchao Ni, DUQUN CHEN, et al.. (2013). Identification of miR-7 as an oncogene in renal cell carcinoma. Journal of Molecular Histology. 44(6). 669–677. 72 indexed citations
20.
CHEN, DUQUN, Yifan Li, Zuhu Yu, et al.. (2012). Upregulated microRNA-16 as an oncogene in renal cell carcinoma. Molecular Medicine Reports. 12(1). 1399–1404. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026